Bone Biologics Corp Common Stock (BBLG) is a publicly traded Healthcare sector company. As of July 8, 2026, BBLG trades at $1.45 with a market cap of $2.59M and a P/E ratio of -0.56. BBLG moved +0.00% today. Year to date, BBLG is -3.29%; over the trailing twelve months it is -51.00%. Its 52-week range spans $1.05 to $10.08. Rallies surfaces BBLG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bone Biologics Launches $9M ATM Private Placement at $1.42 Per Share: Bone Biologics will issue 2.11 million shares and warrants at $1.42 each in an ATM private placement for $3 million upfront and up to $6 million more upon warrant exercises, totaling $9 million in gross proceeds. Proceeds will fund clinical trials, patent portfolio expansion and general working capital needs.
| Metric | Value |
|---|---|
| Price | $1.45 |
| Market Cap | $2.59M |
| P/E Ratio | -0.56 |
| EPS | $-2.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.08 |
| 52-Week Low | $1.05 |
| Volume | 19.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-3.10M |
| Gross Margin | 0.00% |
BBLG analyst coverage data. Average price target: $0.00.